About Enhancer

Enhancer ID: E_01_0780
Species: human
Position : chr1:156460893-156462893
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Neurodegenerative diseases parkinson's disease (pd)
Pubmed ID:  30072894
Enhancer experiment: Western blot, MTT assay, statistical analysis
Enhancer experiment description: In conclusion, rhynchophylline inhibits MPP+-triggered neurotoxicity by stimulating MEF2D via activating PI3-K/Akt/GSK3? cascade.

About Target gene

Target gene : MEF2D
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: In conclusion, rhynchophylline inhibits MPP+-triggered neurotoxicity by stimulating MEF2D via activating PI3-K/Akt/GSK3? cascade.

About TF

TF name : --
TF experiment: western blot,MTT?,????
TF experiment description: In conclusion, rhynchophylline inhibits MPP+-triggered neurotoxicity by stimulating MEF2D via activating PI3-K/Akt/GSK3? cascade.

About Function

Enhancer function : In conclusion, rhynchophylline inhibits MPP+-triggered neurotoxicity by stimulating MEF2D via activating PI3-K/Akt/GSK3? cascade.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
In conclusion, rhynchophylline inhibits MPP+-triggered neurotoxicity by stimulating MEF2D via activating PI3-K/Akt/GSK3? cascade.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs